nach oben

Erschienen in:

Open Access 01.12.2016 | Original Article

International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results

verfasst von: Jan Damoiseaux, Carlos A. von Mühlen, Ignacio Garcia-De La Torre, Orlando Gabriel Carballo, Wilson de Melo Cruvinel, Paulo Luiz Carvalho Francescantonio, Marvin J. Fritzler, Manfred Herold, Tsuneyo Mimori, Minoru Satoh, Luis E. C. Andrade, Edward K. L. Chan, Karsten Conrad

Erschienen in: Autoimmunity Highlights | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

The International Consensus on ANA Patterns (ICAP) was initiated as a workshop aiming to thoroughly discuss and achieve consensus regarding the morphological patterns observed in the indirect immunofluorescence assay on HEp-2 cells. One of the topics discussed at the second ICAP workshop, and addressed in this paper, was the harmonization of reporting ANA test results. This discussion centered on the issue if cytoplasmic and mitotic patterns should be reported as positive or negative. This report outlines the issues that impact on two major different reporting methods. Although it was appreciated by all participants that cytoplasmic and mitotic patterns are clinically relevant, implications for existing diagnostic/classification criteria for ANA-associated diseases in particular hampered a final consensus on this topic. Evidently, a more concerted action of all relevant stakeholders is required. Future ICAP workshops may help to facilitate this action.

Solomon DH, Kavanaugh AJ, Schur PH (2002) Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47:434–444CrossRefPubMed

Mahler M, Fritzler MJ (2012) The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol 2012:494356CrossRefPubMedPubMedCentral

Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK (2015) A Comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol. doi:10.1007/s12016-015-8510-y

Coons AH, Kaplan MH (1950) Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med 91:1–13CrossRefPubMedPubMedCentral

Mahler M, Meroni PL, Bossuyt X, Fritzler MJ (2014) Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014:315179PubMedPubMedCentral

Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69:1420–1422CrossRefPubMed

Fritzler MJ (2011) The antinuclear antibody (ANA) test: last or lasting gasp? Arthritis Rheum 16:19–22CrossRef

Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M et al (2014) International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73:17–23CrossRefPubMed

Dellavance A, Junior AG, Cintra AFU, Ximenes AC, Nuccitelli B, Taliberti BH et al (2003) Brazilian consensus on antinuclear antibodies in HEp-2 cells. Definitions for standardization of autoantibody testing against the nucleus (ANA HEP-2), nucleolus, cytoplasm and mitotic apparatus, as well as its clinical associations. Rev Bras Reumatol 43:129–140

10.

Damoiseaux J, Andrade LE, Fritzler MJ, Shoenfeld Y (2015) Autoantibodies 2015: from diagnostic biomarkers toward prediction, prognosis and prevention. Autoimmun Rev 14:555–563CrossRefPubMed

11.

Chan EK, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PL et al (2015) Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol 6:412CrossRefPubMedPubMedCentral

12.

Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T et al (2009) Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann NY Acad Sci 1173:166–173CrossRefPubMed

13.

Damoiseaux J, Bakker-Jonges L, Cohen Tervaert JW, Derksen R, Hooijkaas H, Kallenberg C et al (2010) Laboratory diagnosis of ANA, anti-ds-DNA- and anti- ENA-antibodies: recommendation following the outcomes of a questionnaire. Ned Tijdschr Klin Chem Labgeneesk 35:234–239

14.

Francescantonio PL, de Melo Cruvinel W, Dellavance A, Andrade LE, Taliberti BH et al (2014) IV Brazilian guidelines for autoantibodies on HEp-2 cells. Rev Bras Reumatol 54:44–50CrossRefPubMed

15.

Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E et al (2013) Choosing wisely: the American College of Rheumatology’s top 5 list of things physicians and patients should question. Arthritis Care Res Hoboken 65:329–339CrossRefPubMedPubMedCentral

16.

Van Blerk M, Bossuyt X, Humbel R, Mewis A, Servais G, Tomasi JP et al (2014) Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing. Acta Clin Belg 69:83–86CrossRefPubMed

17.

Herold M, Klotz W, Demel U, Endler G, Forster E, Griesmacher A et al (2015) International consensus on ANA determination—what changes in the German-speaking area? LaboratoriumsMedizin 39:145–152CrossRef

18.

Carballo OG, Ingenito FB, Ginaca AA, Carabajal P, Costa MA, Balbaryski J (2012) First Argentine consensus for standardization of antinuclear antibodies by indirect immunofluorescence-HEp-2. Acta Bioquím Clín Latinoam 46:3–13

19.

Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE (2011) ANA-HEp-2 pattern is a critical parameter for discriminating ANA-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 63:191–200CrossRefPubMed

20.

Op De Beeck K, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D et al (2011) Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 10:801–808CrossRefPubMed

21.

Bossuyt X, Hendrickx A, Frans J (2005) Antinuclear antibody titer and antibodies to extractable nuclear antigens. Arthritis Rheum 53:987–988CrossRefPubMed

22.

Damoiseaux JG, Tervaert JW (2006) From ANA to ENA: how to proceed? Autoimmun Rev 5:10–17CrossRefPubMed

23.

Bonroy C, Verfaillie C, Smith V, Persijn L, De Witte E, De Keyser F et al (2013) Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med 51:1771–1779PubMed

24.

Schouwers S, Bonnet M, Verschueren P, Westhovens R, Blockmans D, Mariën G et al (2014) Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clin Chem Lab Med 52:547–551CrossRefPubMed

25.

Fritzler MJ, Hanson C, Miller J, Eystathioy T (2002) Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate. J Clin Lab Anal 16:103–108CrossRefPubMed

26.

Wiik AS, Hoier-Madsen M, Forslid J, Charles P, Meyrowitsch J (2010) Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 35:276–290CrossRefPubMed

27.

Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed

28.

Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRefPubMedPubMedCentral

29.

Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res 64:475–487CrossRef

30.

Amigues JM, Cantagrel A, Abbal M, Mazieres B (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol 23:2055–2062PubMed

31.

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral

32.

Meroni PL, Biggioggero M, Pierangeli SS, Sheldon J, Zegers I, Borghi MO (2014) Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases. Nat Rev Rheumatol 10:35–43CrossRefPubMed

33.

Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938CrossRefPubMed

34.

Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176CrossRefPubMed

35.

Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D (2014) Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev 13:435–440CrossRefPubMed

36.

Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A et al (2015) Distinctions Between Diagnostic and Classification Criteria? Arthritis Care Res Hoboken 67:891–897CrossRefPubMedPubMedCentral

37.

Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP et al (2004) Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 41:677–683CrossRefPubMed

Titel: International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results
verfasst von: Jan Damoiseaux
Carlos A. von Mühlen
Ignacio Garcia-De La Torre
Orlando Gabriel Carballo
Wilson de Melo Cruvinel
Paulo Luiz Carvalho Francescantonio
Marvin J. Fritzler
Manfred Herold
Tsuneyo Mimori
Minoru Satoh
Luis E. C. Andrade
Edward K. L. Chan
Karsten Conrad
Publikationsdatum: 01.12.2016
Verlag: Springer International Publishing
Erschienen in: Autoimmunity Highlights / Ausgabe 1/2016
Print ISSN: 2038-0305
Elektronische ISSN: 2038-3274
DOI: https://doi.org/10.1007/s13317-016-0075-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement

Disease prevalence in a rural Andean population of central Peru: a focus on autoimmune and allergic diseases

Reactive oxygen species in organ-specific autoimmunity

Deciphering the role of DNA methylation in multiple sclerosis: emerging issues

Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis

Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin